Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Apomorphine”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 613 records · Page 34Linked to original sources

Circadian variation in the ambulation-increasing effect of apomorphine after repeated administration in mice.

Circadian variation in the ambulation-increasing effect of apomorphine was investigated after repeated administration in mice. The mice housed in a 12 hr light-dark situation (light period; 6:00-18:00) were treated with apomorphine (0.5 mg/kg) or physiological saline vehicle sc at one of 6 times of day (3:30, 7:30, 11:30, 15:30, 19:30 and 23:30). The same treatment was carried out 5 times at intervals of 7 days, and the ambulatory activity was measured for 1 hr after each administration. Repeated administration of apomorphine produced a reverse tolerance (an augmentation in the activity) to the drug. However, the circadian variation in the activity, which was at maximum during the late dark period (administration at 3:30) and at minimum during the late light period (administration at 15:30), was well maintained even after the repeated administration. The circadian variation in the ambulatory activity observed at the 1st administration in the saline-treated control mice, which was at maximum and minimum during the late dark period and mid light period (administration at 11:30), respectively, tended to abolish after the repeated saline administration. The mice that experienced repeated administration of apomorphine exhibited a cross reverse tolerance to methamphetamine (1 mg/kg sc). The cross reverse tolerance occurred throughout the day, and the circadian variation in the effect of methamphetamine, which was similar to that of apomorphine, was also maintained.

Animals↗

Effect of naloxone on apomorphine-induced changes in locomotor activity of stress-exposed rats.

Acute and subacute effects of naloxone (10 mg/kg), apomorphine (0.125 mg/kg; 5 mg/kg) and stressful stimuli (immobilization, cold and sound) on locomotor activity were examined. In both acute and subacute (8 days) treatments, the lower dose of apomorphine decreased locomotor activity and the higher dose of apomorphine increased it. In the acute treatment, naloxone enhanced significantly the depressant effect of the lower dose of apomorphine on locomotor activity. Stress seemed to have no effect on apomorphine induced changes in locomotor activity of rats either in acute or in subacute treatment.

Acoustic Stimulation↗

Augmentation of sensitivity to ambulation-increasing effect of apomorphine induced by repeated administration in mice.

Effect of apomorphine on ambulatory activity in mice was investigated after single and repeated administration. The activity was measured by a tilting-type round activity cage of 20 cm in diameter. Single administration of apomorphine at doses of 0.016-0.13 mg/kg sc tended to decrease the ambulatory activity, while doses of 0.5-4 mg/kg sc increased it. Repeated administration of apomorphine (0.5 mg/kg sc) at intervals of 1 hr, 1 day and 7 days induced an augmentation of sensitivity to the ambulation-increasing effect of the drug regardless of the administration intervals. The same treatments of apomorphine (1 mg/kg sc) produced neither augmentation nor tolerance to it. However, the mice exhibited stereotyped behaviors such as sniffing and climbing after the repeated administration, although they hardly exhibited the stereotyped behaviors on the 1st administration. The augmentation of sensitivity, once produced, was well maintained 1 month after cessation of the repeated administration. The augmentation of sensitivity to apomorphine was produced in mice which had repeatedly exposed to both experimental situations in which the ambulation was freely allowed and perfectly restricted, respectivity, during presence of the acute drug effect.

Animals↗

Effects of single and repeated application of clonazepam and diazepam independently and in combination with cyproheptadine on apomorphine stereotypy in rats.

The effects of the benzodiazepines clonazepam (CLZ) and diazepam (DZ), introduced independently and in combination with cyproheptadine (CY) upon single and repeated application on apomorphine stereotypy in rats were studied. On single application CLZ shortened the duration of apomorphine stereotypy and DZ did not change it. On repeated application (14 days) CLZ reduced stereotypy while DZ increased it. Cyproheptadine on both single and repeated application reduced apomorphine stereotypy. On single application the combination of CLZ and CY increased stereotypy and the combination of DZ and CY increased gnawing behavior. On repeated administration the combination of CLZ and CY reduced apomorphine stereotypy to a higher extent than did CLZ when applied alone. The CLZ- and DZ-induced changes in apomorphine stereotypy were determined through a mediated effect in which 5-hydroxytryptamine plays an important role.

Animals↗

Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.

The effects of dopaminergic and serotonergic antagonists on apomorphine- and dopamine-induced changes in body temperature were studied in the rat. Intraperitoneal administration of apomorphine produced dose-dependent hypothermia. At a dose of 0.1 mg/kg, apomorphine caused either no significant effect or a slight decrease in body temperature. However, it caused hyperthermia in rats pretreated with the DA antagonist, haloperidol, and hypothermia in rats pretreated with the serotonin depletor, p-chlorophenylalanine or serotonin antagonists, cyproheptadine, metergoline or cinanserin. Intracerebroventricular injection of 100 micrograms/2 microliter of DA transiently decreased body temperature. Pretreatment with cyproheptadine potentiated and prolonged the responses. However, the same injection of DA produced hyperthermia in haloperidol-pretreated animals. These data suggest that both dopaminergic and serotonergic mechanisms in the brain mediate the effects of apomorphine on body temperature. We propose that apomorphine can simultaneously activate two opposing DA-related thermoregulatory mechanisms with different sensitivities to haloperidol: a haloperidol-sensitive hypothermia and a haloperidol-nonsensitive hyperthermia mechanisms. Furthermore, the action of the latter mechanism is mediated by a secondary activation of serotonergic mechanisms.

Animals↗

Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.

The release of dopamine (DA) and of acetylcholine (ACh) was monitored from rabbit striatal slices labeled with [3H]DA and [14C]choline. Chronic treatment with haloperidol (1 mg/kg b. wt. for 28 days, sacrifice 96 hr after last injection) increased the potency of in vitro apomorphine in inhibiting the release of DA and ACh evoked by electrical stimulation when compared to vehicle-treated rabbits. Potentiation of apomorphine effects was greater on DA than on ACh release. The effects of in vitro haloperidol on DA and ACh release and in antagonizing the inhibitory effects of apomorphine were not modified by chronic treatment with haloperidol. Bromocriptine (1.5 mg/kg b.wt. for 7 days, sacrifice 72 hr after last injection) did not affect the evoked release of DA and of ACh, or the sensitivity to apomorphine. However, 15 mg/kg b.wt. of bromocriptine for 7 days and sacrifice 72 hr after last injection, produced a 60 to 70% reduction in the evoked release of DA and ACh, and markedly antagonized the inhibition of DA and ACh release produced by apomorphine. These results indicate that the DA receptors which modulate the release of DA and of ACh play an important physiological role inasmuch as they develop adaptational changes after prolonged receptor activation or inhibition by DA agonists and antagonists, respectively. These adaptational changes affect the potency of DA agonists on release modulatory receptors without modifying that of DA antagonists. The possibility that bromocriptine has a residual agonistic effect on striatal DA receptors 3 days after the last injection cannot be ruled out.

Acetylcholine↗

hypobaric hypoxia: central catecholamine levels and cortical PO2 and avoidance response in rats treated with apomorphine.

The learning of a conditioned avoidance response, the catecholamine levels in some cerebral structures, and the evolution of the cortical PO2, were studied under hypobaric hypoxia (300 torr) and under normoxia, in rats treated or not with apomorphine, at the dose of 1 or 10 mg/kg i.p. Apomorphine at 1 mg/kg improves the learning capacity and stabilises the cerebral catecholamine levels under hypoxia; no modification of the evolution of the cortical PO2 during hypoxia was observed between control rats and rats treated with this dose of apomorphine. Apomorphine at 10 mg/kg totally inhibits learning under normoxia or hypoxia. It is therefore possible to suppose that the antihypoxic protective mechanism of low-dose apomorphine is due to a stabilization of the levels of both dopamine and noradrenaline during hypoxia, but not to an increase in the cerebral oxygen availability. These data suggest the clinical possibility of using other dopaminergic stimulating agents for their eventual antihypoxic properties.

Air Pressure↗

Internal vomiting in the ruminant: effect of apomorphine on ruminal pH in sheep.

Five sheep, with a rumen fistula inserted, were each injected (IV) with apomorphine (18 mg) and ruminal pH was measured every 5 minutes during a 1-hour period. During the base-line period (30 minutes) that preceded apomorphine injection, pH was constant in individual sheep and te group mean (+/- SD) was 7.1 +/- 0.35. After apomorphine was injected, group mean was 6.9, 6.0, 6.3, 6.3, 6.3, 6.4, 6.4, 6.5, 6.7, 6.9, 6.9, and 7.1 at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes, respectively. The pH reduction of ruminal content was recorded in 4 of the sheep. Maximal reduction occurred in the 10-minute period after apomorphine was injected. The pH returned to control value within 40 to 50 minutes after injection. Vomitus was not expelled through the mouth by any of the sheep. It was concluded that expulsion of acidic abomasal contents back into the preabomasal compartment (internal vomiting) was the cause of acidification of the rumen after apomorphine was injected.

Animals↗

Apomorphine and oxotremorine hypothermia in the pigeon: dopaminergic-cholinergic interaction and the effect of paleostriatal lesions.

The role of central dopaminergic and cholinergic systems and their interaction in avian temperature regulation was studied. Pigeons were injected with apomorphine intrahypothalamically and apomorphine and oxotremorine intramuscularly (i.m.) at 20 degrees C. The injections caused suppression of shivering, a decline in body temperature, and with the i.m. injections most frequently a transient increase in foot temperature. Pretreatment with atropine (i.m.) did not affect hypothermia induced by i.m. apomorphine. Bilateral electrolytic lesions placed in the dopamine and acetylcholinesterase-rich brain region (paleostriatum augmentatum) did not attenuate the responses to i.m. apomorphine and oxotremorine. These results suggest that medial aspects of paleostriatum augmentatum in the pigeon do not contribute to hypothermia induced by dopaminergic and cholinergic stimulation of the brain. They also indicate that no cholinergic link is involved in mechanisms mediating the hypothermic effects of i.m. apomorphine.

Animals↗

The involvement of serotonin in the mechanism of central action of apomorphine.

The paper reviews and summarizes the results obtained in a series of experimental papers on the action of apomorphine on central serotonin mechanisms. Apomorphine accelerates utilization of serotonin in the central nervous system, this effect being a consequence of stimulation of central dopamine receptors. The activation of serotonergic mechanisms may be responsible for the hypothermizing action of apomorphine in rats and mice, pi modulates the locomotor stimulation produced by apomorphine in the rat, and does not influence the apomorphine-induced stereotypy in the rat.

Animals↗

Effect of apomorphine on rat motor activity induced by fencamfamine and other indirect psychostimulant drugs.

We evaluated the effects of low doses of apomorphine on the stimulant behavioral effects induced by amphetamine (2.5 mg/kg), fencamfamine (6.0 mg/kg) and cocaine (15.0 mg/kg). Rats received 0.02 mg/kg of apomorphine (sc) and 30 min later were injected with one of the stimulants. Motor activity including locomotion, rearing and sniffing was quantified in the animals home cages for 60 min at 15-min intervals. All stimulant drugs induced hyperactivity. When apomorphine was administered before cocaine, but not when administered before fencamfamine or amphetamine, distinctive changes occurred. The behavioral pattern resulting from high stimulation was replaced by that related to low stimulation, suggesting that apomorphine induces a transfer in the predominant behavior in cocaine-, and partially in fencamfamine-, but not in amphetamine-treated animals, by decreasing the intensity of the stereotyped effect. While no changes occurred when apomorphine was administered before amphetamine, the fencamfamine group showed intermediate alterations (nonsignificant changes in sniffing but a significant increase in rearing behavior). These results are discussed in terms of the different mechanisms of presynaptic action of the drugs studied.

Amphetamine↗

Variations in the behavioral responses to apomorphine in different strains of rats.

The present experiments compared patterns of locomotor activity during repeated acclimation sessions and determinations of locomotion and stereotypy elicited by administration of the direct dopamine receptor agonist apomorphine in five inbred strains of rats: the results suggest that each strain can be differentiated phenotypically according to these behavioral responses. Brown Norway rats demonstrated the greatest locomotion during acclimation sessions. Low doses of apomorphine (0.1 and 0.32mg/kg) produced a flat body posture in Lewis animals. A higher dose of apomorphine (1.0mg/kg) markedly increased locomotion in Fisher rats. Buffalo animals showed licking during control sessions and the greatest increase in gnawing at higher doses of apomorphine. DA rats were less responsive than the other strains of apomorphine. Between-strains autoradiographic determination of dopamine receptor densities revealed several differences in D1 receptors labeled by (3)H-SCH 23390 and D2/D3 receptors labeled by (125)I-NCQ 298 in the caudate-putamen and nucleus accumbens. However, the heterogeneity of dopamine receptor densities was not sufficient to explain the strain-specific behavioral responses. These experiments demonstrate variations in behavioral and neurochemical characteristics of inbred strains of rats which could be used to model genetically determined differences in dopamine-mediated behavioral responses.

Journal Article↗

Dopamine and serotonin neurotransmission in the reinforcing effects of alcohol and apomorphine.

OBJECTIVE: To determine the role of dopamine and 5-hydroxytryptamine (5-HT; serotonin) in the reinforcing effects of alcohol and apomorphine. DESIGN: Experimental study. PLACE AND DURATION OF STUDY: Department of Biochemistry, University of Karachi from September to November 2004. SUBJECTS AND METHODS: The study was conducted on 24 male albino Wistar rats. Reinforcing effects were monitored in a conditioned place preference (CPP) paradigm using a light-dark activity box. Slicing and punching method was used to collect dorsal and ventral striatum. Neurochemical estimations were done by HPLC-EC. RESULTS: Withdrawal from repeated administration of ethanol (1g/kg/day) as well as apomorphine (1 mg/kg/day) elicited reinforcement that could be monitored in a CPP paradigm. CNS depressant effects of ethanol were not altered on repeated administration but CNS stimulatory effects of apomorphine increased. Reinforcing effects of ethanol but not apomorphine were associated with a decrease in dopamine metabolism in the ventral striatum. CONCLUSION: A decrease in the activity of dopaminergic neurons following withdrawal from repeated administration is involved in the compulsive use of abused drugs.

Animals↗

Intranasal apomorphine in parkinsonian on-off fluctuations.

The efficacy of intranasal apomorphine was assessed in seven patients with Parkinson's disease and severe levodopa (L-dopa)-related "off-period" disabilities. All patients responded favorably to treatment with intranasal apomorphine. The speed and the quality of motor response and the pharmacokinetic profile showed results similar to those seen after subcutaneous injection of apomorphine administered by insulin pen syringe. The simplicity in the technique of intranasal apomorphine administration was found to be superior by all patients.

Administration, Intranasal↗

Effects of spinal alpha 1-adrenoceptor antagonism on bladder activity induced by apomorphine in conscious rats with and without bladder outlet obstruction.

To test the hypothesis that the spinal control of micturition involves alpha 1-adrenoceptors, the urodynamic effects of intrathecal and intraarterial alpha 1-adrenoceptor blockade on apomorphine-induced bladder activity in rats were studied. Continuous cystometry was performed in conscious female Sprague-Dawley rats with and without bladder outflow obstruction. In normal rats, subcutaneous apomorphine, 30 micrograms/kg, induced bladder activity that was abolished or attenuated by the alpha 1-adrenoceptor antagonists indoramin and doxazosin given intrathecally or intra-arterially. In rats with outlet obstruction, apomorphine 30 micrograms/kg caused no change in cystometric parameters. However, at a dose of 100 micrograms/kg the drug induced bladder activity, which was attenuated by intrathecal indoramin or doxazosin. These results suggest that the bladder activity evoked by apomorphine-stimulation of bulbospinal pathways can be influenced by alpha 1-adrenoceptors at the spinal and peripheral levels, both in normal rats and in rats with bladder hypertrophy secondary to outlet obstruction.

Adrenergic alpha-Antagonists↗

Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease.

OBJECTIVE: To determine the effect of a single dose of apomorphine on internal globus pallidus (GPi) neuronal discharge in patients with Parkinson's disease (PD). PATIENTS AND METHODS: Nine PD patients who underwent microelectrode-guided posteroventral pallidotomy (PVP) were studied. After identification of a single GPi unit discharge with sufficient spike S/N ratio to allow reliable thresholding, basal recording was followed by a single 3-mg subcutaneous injection. One-minute samples were recorded 10', 30', and 60' after apomorphine. RESULTS: In four patients, recording was lost after 5-10 minutes. In two, changes were observed at peak-of-dose but recording was then lost, whereas three completed recording and returned to baseline, all five showing significant reduction in GPi firing rate (mean +/- standard deviation for basal and post-apomorphine were 143+/-55.6 and 52+/-19.2, respectively; p <0.002). CONCLUSION: In patients with PD, apomorphine induces changes in GPi spontaneous discharge and modifies firing rates resembling recordings in normal primates. These findings show that clinical improvement as well as induction of dyskinesias following DA administration could be mediated by reduction of GPi outflow.

Antiparkinson Agents↗

Peripheral pharmacokinetics of apomorphine in humans.

Apomorphine, a potent dopamine agonist, has been used in acute and chronic studies of parkinsonism and other neurological disorders. To define its peripheral pharmacokinetics, we administered apomorphine by subcutaneous injection, by subcutaneous infusion, and by intravenous infusion to 15 patients with parkinsonism and measured plasma apomorphine levels by high-performance liquid chromatography with electrochemical detection. The peak drug levels and area under the curve were closely correlated with the dose administered; time to peak was brief and was independent of dose. The variation in absorption was high between subjects but low within individual subjects. In 11 of 15 subjects, the disappearance of drug could be described by a two-compartment model, with a distribution half-life of 5 minutes and an elimination half-life of 33 minutes. The drug absorption, volume of distribution, plasma clearance, and half-lives were similar for subcutaneous injection, subcutaneous infusion, and intravenous infusion. We conclude that apomorphine is rapidly and completely absorbed from subcutaneous tissue, correlating with the rapid onset of clinical effects, and that the brief duration of clinical action of the drug is explained by its rapid clearance.

Adult↗

Defecatory function in Parkinson's disease: response to apomorphine.

We evaluated the effects of the dopaminergic agent apomorphine on defecation and anorectal function in patients with Parkinson's disease (PD). A gastrointestinal symptom survey, extrapyramidal assessment, defecating proctogram, and anorectal manometric study were performed in 8 subjects with PD. Basal studies showing abnormalities were repeated following apomorphine administration. Prior defecographic abnormalities were normalized following apomorphine injection in 1 of 3 subjects and significant improvements in manometric parameters were observed in all 5 subjects who underwent repeat anorectal manometry. We conclude that apomorphine can correct anorectal dysfunction in PD, and that these abnormalities may be a consequence of dopamine deficiency secondary to the PD process. These findings may also have therapeutic implications.

Aged↗